Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy. - Wikidata - wikimedia - TriplyDB

Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy.

Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy.

http://www.wikidata.org/entity/Q36478656

about

Peptide carrier-mediated non-covalent delivery of unmodified cisplatin, methotrexate and other agents via intravenous route to the brain Synergistic interaction between selective drugs in cell populations models Therapeutic strategies to improve drug delivery across the blood-brain barrier.Focused ultrasound-induced blood-brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study.Image-guided convection-enhanced delivery platform in the treatment of neurological diseases.Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines.Phase I trial of systemic intravenous infusion of interleukin-13-Pseudomonas exotoxin in patients with metastatic adrenocortical carcinoma.A novel bispecific ligand-directed toxin designed to simultaneously target EGFR on human glioblastoma cells and uPAR on tumor neovasculature.Interleukin-13 is overexpressed in cutaneous T-cell lymphoma cells and regulates their proliferation.IL-13Rα2-Targeted Therapy Escapees: Biologic and Therapeutic Implications.Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylated liposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenografts.Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel.A mathematical model for the rational design of chimeric ligands in selective drug therapies.A novel and generalizable organotypic slice platform to evaluate stem cell potential for targeting pediatric brain tumors Identification of interleukin-13 receptor alpha2 chain overexpression in situ in high-grade diffusely infiltrative pediatric brainstem glioma.Targeted therapies for malignant glioma: progress and potential.Pharmacogenomics of brain cancer and personalized medicine in malignant gliomas.Overexpression of interleukin-13 receptor-alpha2 in neuroendocrine malignant pheochromocytoma: a novel target for receptor directed anti-cancer therapy.Imaging immune response in vivo: cytolytic action of genetically altered T cells directed to glioblastoma multiforme.Targeted drug delivery for treatment and imaging of glioblastoma multiforme.Review: on TRAIL for malignant glioma therapy?Advances in the treatment of neurodegenerative disorders employing nanotechnology.Overcoming the blood-brain barrier in chemotherapy treatment of pediatric brain tumors.The role of targeted therapies in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.Immunotoxin: A new tool for cancer therapy.A novel ligand delivery system to non-invasively visualize and therapeutically exploit the IL13Rα2 tumor-restricted biomarker.Intracranial elimination of human glioblastoma brain tumors in nude rats using the bispecific ligand-directed toxin, DTEGF13 and convection enhanced delivery.IL-13 cytotoxin has potent antitumor activity and synergizes with paclitaxel in a mouse model of oral squamous cell carcinoma.Anti-glioblastoma effect of a recombinant bispecific cytotoxin cotargeting human IL-13 and EGF receptors in a mouse xenograft model.Intracranial therapy of glioblastoma with the fusion protein DTAT in immunodeficient mice.Recombinant Immunotoxin Therapy of Glioblastoma: Smart Design, Key Findings, and Specific Challenges.Local chemotherapy in the rat brainstem with multiple catheters: a feasibility study.Gene therapy with HSV1-sr39TK/GCV exhibits a stronger therapeutic efficacy than HSV1-TK/GCV in rat C6 glioma cells.

P2860

Q27331875-D351D972-A870-4F29-8DF5-86BD34D1EDEF Q28543382-435DCD58-25A9-46D7-A899-B54E1D48D3BC Q30407443-E0367C08-60CE-400A-8C7C-0BE9B67541B5 Q30416228-6C94BE7C-75EB-4A6E-AB0C-5FE9241735DE Q31141544-098CF473-A4B6-42F5-B055-8DC9E569C920 Q33297502-8A98FCBE-DACD-4DBE-B43F-CADBA90F8BC2 Q33421178-23D7B439-B80A-44B1-A9F2-1EEC3A90AD07 Q34993336-68234D83-928A-4752-BB86-8C2F6BC3638F Q35584244-1FCE337B-A4E2-48D8-BF9C-0DA7D62079FD Q35626536-3336A37B-B069-489F-A8B3-59BBBC03A1A0 Q36013320-7ACE661A-F58F-4270-89EC-75228C004B33 Q36280722-C9D08C6A-DD93-48C5-84CC-241D7A2B4CF8 Q36693739-BA369482-36AC-4B4B-8986-7940FF42CBC3 Q36775537-6F63E0EA-5B2E-48E1-B06B-76DF1A539011 Q36926747-F8880D8B-9170-4C54-B253-850458F1AF75 Q37159549-F16680FC-C004-436E-AC54-236F6B50CF52 Q37236431-15E7295C-80AF-4227-984F-B3DF6AF78C40 Q37315697-E55858E5-499B-437B-A19C-685B83AFFA07 Q37332250-EC6B4D29-C63E-4DB6-AA36-6C313CCEC3CE Q37523966-4A66A579-1E6A-4497-9AD2-ED4DA103887E Q37681647-D088B3B5-5321-4CA4-AE6D-5942618DF7A1 Q37690357-23569128-E7B5-4E7A-B1E7-9EE22DDA02B0 Q38133407-15636F9B-8A01-4541-8BB8-E3A2D0D6C132 Q38205134-4A3E14FB-4C5F-45B6-96F8-05AE09601BA0 Q39144131-961800FC-C32C-4F98-8562-5F5EBFA35B14 Q39284797-BFD3FB99-0687-490C-B3A0-7B38ABF9B3F5 Q39839534-C8994333-F822-4AF7-B693-9AC90A17F0E6 Q39907590-F3629495-7317-41DD-AE76-C6048EDBFF41 Q40034753-A631D22B-1061-46C3-9320-3010599CAEA7 Q40213943-7D32547C-A505-4F7F-86EE-1DBE9D07C9E5 Q41022992-E7911B11-058C-470D-A444-17C132C67A7D Q46438304-13604851-1029-4BFB-BED7-458AC4F072A6 Q51467919-322CC152-519B-4368-A597-66493527C011

P2860

Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy.

http://www.wikidata.org/entity/Q36478656

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Convection-enhanced delivery o ...... for malignant glioma therapy.

@ast

Convection-enhanced delivery o ...... for malignant glioma therapy.

@en

type

label

Convection-enhanced delivery o ...... for malignant glioma therapy.

@ast

Convection-enhanced delivery o ...... for malignant glioma therapy.

@en

prefLabel

Convection-enhanced delivery o ...... for malignant glioma therapy.

@ast

Convection-enhanced delivery o ...... for malignant glioma therapy.

@en

P1433

Q36478656-D30D5A0B-2457-4FD9-8688-F8372185ACAE

P1476

Q36478656-1887BA63-B3E7-42EA-8CF0-07F1838E67A1

P2093

Q36478656-364DA607-1E34-43EB-95B9-C307338485D9

Q36478656-3DD2FA38-AF09-424D-BC4F-BB560BF04BBD

Q36478656-B0ED7356-2475-4F67-A3E3-F563BCD787C5

Q36478656-B5D2DBAE-7234-4FEA-AEF0-972675FC3DA6

Q36478656-BCF47BE6-FF71-4497-B1EC-A281ACC41044

P2860

Q36478656-00AD98A2-A6D7-48F8-B41A-752E2CC5D4A4

Q36478656-03B5E381-EA0E-4E0B-89BF-0F7D1C88AF4F

Q36478656-04ECCAC5-9000-4068-8BE5-62C6C1EF66A2

Q36478656-0AA3300F-1398-4BD9-9AD3-B4F107DABCE8

Q36478656-0F40AC48-E193-4420-A2AE-A089164EB288

Q36478656-14978F77-F821-4D43-8D15-79A5657178D3

Q36478656-1B2761EA-F0A8-48E0-B091-2B1C627B0706

Q36478656-1F87D39F-E514-4E25-8E03-D773D1F17977

Q36478656-2BBACBB6-BBCA-4186-8B19-8FB1E5A6473F

Q36478656-2DB553FD-D63A-400A-A865-F46DF9DF2EA6

P304

Q36478656-10B8A386-8851-4821-AC03-9D84E9CF8DE7

P31

Q36478656-166FB888-DF51-4100-A0CE-D44415CFF746

Q36478656-c2dea29d-b0c1-4f39-a43a-4908dd3247f5

P356

Q36478656-9A694496-4D7F-437C-BC8D-7E8DA79D4CFA

P433

Q36478656-CB3A1CD4-E198-4914-8C32-EB30B98A19F7

P478

Q36478656-0C295E54-61C9-4339-BC8B-B0BA5955CBC2

P577

Q36478656-BAF7A8C5-5E60-4EFA-9BD7-D8374EB94EC1

P5875

Q36478656-050484F3-297C-4188-814A-E0AD29645DEB

P698

Q36478656-DA561583-2A73-46F8-A99C-9A67145B2ED7

P921

Q36478656-1111CC12-9972-4ABB-A01A-3B4A299FA74E

P356

153303460600500307

P1433

Technology in Cancer Research and Treatment

P1476

Convection-enhanced delivery o ...... for malignant glioma therapy.

@en

P2093

David Croteau

http://www.w3.org/2001/XMLSchema#string

Mitomu Kioi

http://www.w3.org/2001/XMLSchema#string

Raj K Puri

http://www.w3.org/2001/XMLSchema#string

Sandeep Kunwar

http://www.w3.org/2001/XMLSchema#string

Syed R Husain

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses

IL-13 effector functions

Identification of distinct roles for a dileucine and a tyrosine internalization motif in the interleukin (IL)-13 binding component IL-13 receptor alpha 2 chain

Characterization of a powerful high affinity antagonist that inhibits biological activities of human interleukin-13

Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain

IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis

Interleukin-13: central mediator of allergic asthma

Genes that mediate breast cancer metastasis to lung

P304

239-250

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/153303460600500307

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7080156

http://www.w3.org/2001/XMLSchema#string

P698

16700620

http://www.w3.org/2001/XMLSchema#string

P921

convection-enhanced delivery